Table 2 Plectin staining and clinicopathological characteristics of 179 CRC patients.
| Â | Plectin staining | ||||
|---|---|---|---|---|---|
Variables | Low (%) | High (%) | Total | P value | |
Gender | |||||
Male | 55 (59.78) | 37 (40.22) | 92 | 0.288 | |
Female | 48 (54.55) | 40 (45.45) | 88 | ||
Age | |||||
<57 | 29 (63.04) | 17 (36.96) | 46 | 0.227 | |
≥57 | 74 (55.22) | 60 (44.78) | 134 | ||
Tumor size | |||||
T2 | 10 (71.43) | 4 (28.57) | 14 | 0.017 | |
T3 | 49 (65.33) | 26 (34.67) | 75 | ||
T4 | 44 (48.35) | 47 (51.65) | 91 | ||
Lymph node metastasis | |||||
N0 | 65 (60.19) | 43 (39.81) | 108 | 0.345 | |
N1 | 24 (53.33) | 21 (46.67) | 45 | ||
N2 | 14 (51.85) | 13 (48.15) | 27 | ||
Distant metastasis | |||||
Negative | 99 (57.56) | 73 (42.44) | 172 | 0.471 | |
Positive | 4 (50.00) | 4 (50.00) | 8 | ||
Depth of invasion | |||||
T1/T2 | 13 (81.25) | 3 (18.75) | 16 | 0.033 | |
T3/T4 | 90 (54.88) | 74 (45.12) | 164 | ||
Clinical staging | |||||
1 | 8 (66.67) | 4 | (33.33) | 12 | 0.176 |
2 | 56 (60.22) | 37 (39.78) | 93 | ||
3 | 35 (53.03) | 31 (46.97) | 66 | ||
4 | 4 (44.44) | 5 (55.56) | 9 | ||
Clinical grading | |||||
1 | 1 (100.00) | 0 (0.00) | 1 | 0.038 | |
1–2 | 0 (0.00) | 5 (100.00) | 5 | ||
2 | 71 (60.17) | 47 (39.83) | 118 | ||
2–3 | 24 (54.55) | 20 (45.45) | 44 | ||
3 | 7 (58.33) | 5 (41.67) | 12 | ||
Pathologic typing | |||||
Adenocarcinoma | 76 (61.29) | 48 (38.71) | 124 | 0.038 | |
Mucinous adenocarcinoma | 26 (52.00) | 24 (48.00) | 50 | ||
Signet ring cell carcinoma | 1 (16.67) | 5 (83.33) | 6 | ||
